Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Thursday, August 20, 2026

Snapshot: Aug 20, 2026 · 6:00 PM 100 stocks analyzed

Strong Down Day

Thu, Aug 20, 2026 Broad Selloff High

Broad selloff hammers all three indices—S&P -2.0%, Nasdaq -2.7%, Russell -2.0%—while fear spikes 12% and single-stock chaos erupts across 50 gainers and 50 losers.

60% Broad market rout across all equity indices with S&P 500 down 2.02%, Nasdaq Composite falling 2.75%, and Russell 2000 sliding 1.98%, driven by risk-off sentiment as VIX jumped 12.35% signaling a sharp shift in investor sentiment away from equities. The Dow Jones fell 2.01% as buyers capitulated across mega-cap, mid-cap, and small-cap territory without meaningful sector refuge.
25% Extreme dispersion in individual stocks with 50 gainers averaging +21.8% (led by HOWL's 92% surge) and 50 losers averaging -27.1% (with ZVZZT crashing 86%), suggesting a stock-pickers market where tactical selection mattered far more than broad positioning; Technology bore the heaviest load in losers at 24% of the bottom 50, matching its 22% share in gainers.
15% News-grounded catalysts drove a handful of moves: GWH slumped 42% after ESS Tech announced a dilutive $3.2M capital raise, AAP tanked 24.5% on earnings collapse, MRNA fell 20.7% as investors took profits after a 175% surge, and SUGP rallied 29% on Nasdaq compliance confirmation, while ZTG extended a 4-day losing streak without fresh negative headlines, signaling persistent weakness in select micro-caps.

5 names returned after long absences ZTG · 4-day losers streak LGCL · 3-day losers streak WTG — first appearance CLPS — first appearance

Market Regime

Thu, Aug 20, 2026 Neutral conf: medium macro · prototype

+17

Tailwind −100 … +100 · + tailwind / − headwind

VIX16.0 p28 Drawdown-2.0% Held1d · nascent SinceAug 20

Top drivers: VIX percentile ▲ S&P 20d return ▲ S&P drawdown (60d) ▲

processId: history-market-regime

Market Indexes

Thu, Aug 20, 2026 13

S&P 500

7,641.16

−157.83

-2.02%

Dow Jones

52,759.21

−1,080.78

-2.01%

NASDAQ Composite

26,067.17

−735.86

-2.75%

NASDAQ 100

29,213.16

−871.34

-2.90%

DJ US Total Market

75,692.75

−1,620.48

-2.10%

Russell 1000

4,166.33

−86.29

-2.03%

S&P MidCap 400

3,810.89

−103.54

-2.65%

Russell 2000

2,992.43

−60.42

-1.98%

Russell 2500

1,279.60

−12.64

-0.98%

Russell 3000

4,349.88

−90.00

-2.03%

Nasdaq Financial-100

7,569.84

+4.88

+0.06%

NIFTY 50

24,231.85

−134.15

-0.55%

VIX

16.01

+1.76

+12.35%

Biggest Gainers

Thu, Aug 20, 2026 50

HOWL

Werewolf Therapeutics, Inc.Healthcare

$0.43+$0.38

+92.0%

NASDAQ · Mkt cap $20 M

Werewolf Therapeutics surged 92% today, but no news headlines were available in the past 48 hours to explain the move, making the cause unclear from public information.

The absence of recent news headlines is notable for a stock that jumped to the 1 biggest gainer of the day. For a micro-cap biotech like Werewolf Therapeutics, large single-day moves can be driven by several categories of catalyst: clinical trial results or regulatory updates that may have been announced but not yet indexed in the RSS feeds checked, short-covering or options-related technical buying in a thinly traded name, insider trading activity, or delayed market reaction to earlier announcements. The 91.99% gain from a $0.43 price point suggests relatively low absolute liquidity, meaning even modest-volume accumulation can produce outsized percentage moves. Without confirmatory headlines, the specific driver remains speculative, though biotech stocks at this price level are often sensitive to clinical or regulatory developments.

WTG

Wintergreen Acquisition Corp.

$10.50+$7.84

+74.8%

INDP

Indaptus Therapeutics, Inc.Healthcare

$1.36+$0.40

+42.6%

NASDAQ · Mkt cap $125 M

No news headlines were available in the last 48 hours to explain the 42.55% rally in INDP stock, so the precise catalyst remains unknown, though this type of biotech microcap is prone to sharp moves on clinical trial outcomes, regulatory filings, or technical trading.

Despite a significant intraday gain that ranks INDP as the third biggest mover on NASDAQ today, no headlines were found in the Yahoo Finance RSS feed for the past two days. This absence of reported news does not rule out a catalyst occurring earlier or on a different channel. Indaptus is a small-cap therapeutics company where moves of this magnitude typically correlate with clinical trial announcements, FDA actions, partnership disclosures, or financing events. It is also possible the move reflects delayed market reaction to news released outside the standard 48-hour window, technical accumulation after a prior selloff, or institutional repositioning. Without confirmed headlines, any attribution remains speculative and falls into the inference category rather than established fact.

WETO

Webus International Limited Ordinary SharesTechnology

$27.39+$7.74

+39.7%

NASDAQ · Mkt cap $11 M

No news headlines appeared in the last 48 hours for WETO, so the 39.71% gain likely reflects either a delayed market reaction to an earlier announcement, a technical rebound, or unreported company-specific catalyst not yet indexed by major financial feeds.

The absence of any recent news headlines is striking given the stock's rank as the fourth-largest gainer on the day. Several plausible explanations warrant consideration. First, the move could reflect delayed market pricing of a news event that occurred before the 48-hour window or that has not yet propagated to major news aggregators. Second, for a smaller-cap international listing like Webus International, information asymmetries are common—local announcements or earnings releases may not immediately surface on US financial media. Third, the gain could be technical in nature, such as a short squeeze, options expiration gamma effects, or mean reversion after a prior decline. Fourth, unconfirmed rumors or social media activity sometimes drive significant intraday swings in lower-volume names before official news materializes. Without corroborating headlines or structural knowledge of the stock's characteristics, attributing the move to any single cause would be speculative.

USDE

StablecoinX Inc.Financial Services

$3.99+$1.11

+35.4%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours, so the 35.35% jump in USDE cannot be attributed to a specific announced event. The move likely reflects technical trading, market sentiment shifts, or information not yet indexed by Yahoo Finance.

The absence of recent news headlines is notable given the magnitude of the gain. StablecoinX Inc. is a stablecoin-focused company operating in a volatile and sentiment-driven sector. A 35% single-day move without accompanying news could reflect several factors: renewed bullish sentiment around stablecoins or blockchain infrastructure, technical buying or short covering, sector-wide momentum in digital assets, or a delayed announcement not yet captured by the news feed. It's also possible that meaningful corporate developments occurred but have not yet been reflected in the headline data provided. Without access to the specific driver, any explanation remains speculative.

IPST

Heritage Distilling Holding Company, Inc.Consumer Defensive

$10.26+$2.92

+34.8%

MMA

Alta Global Group LimitedConsumer Cyclical

$0.56+$0.12

+29.6%

NYSE · Mkt cap $10 M

MMA completed a $4 million private placement at $1.00 per share on August 20, priced 160% above the prior closing price, which directly triggered the 29.63% intraday gain as the market repriced the stock upward following the announcement.

The headline establishes a concrete capital event: Alta Global Group Limited announced completion of a $4.0 million private placement at $1.00 per share, representing a substantial premium to the August 19 closing price. The timing of the announcement (August 20, 12:55 UTC) aligns precisely with the +29.63% move on the same day. A private placement at a significant premium typically signals institutional confidence in the company's value and injects capital that can support operations or strategic initiatives. The fact that no warrants or convertible securities were issued suggests a straightforward equity raise without dilutive instruments. This is a direct, identifiable catalyst that markets typically respond to favorably, especially when priced well above recent trading levels.

BIVI

BioVie Inc.Healthcare

$1.86+$0.45

+29.5%

NASDAQ · Mkt cap $10 M

No news headlines were found in the last 48 hours, so the 29.54% gain cannot be directly attributed to a reported event. The move may reflect a delayed market reaction, technical rebound, or untracked development.

BioVie is a small-cap biotech company, and the absence of any Yahoo Finance headlines in the past 48 hours despite an 8th-place ranking gain suggests either a very recent development not yet picked up by major feeds, a technical or sentiment-driven move, or a delayed market reaction to news from earlier in the week. Small biotech stocks are particularly sensitive to clinical trial updates, FDA decisions, partnership announcements, and licensing deals, which can drive sharp single-day moves. Given the lack of visible catalyst in the provided data, the jump could also reflect short covering, options-related buying, or renewed retail interest. Without access to a full news feed or intraday catalysts, the specific driver remains unclear.

SUGP

SU Group Holdings Limited Ordinary SharesIndustrials

$2.78+$0.76

+29.3%

NASDAQ · Mkt cap $6.9 M

SU Group Holdings received written confirmation from Nasdaq that it has regained compliance with the minimum bid price requirement, resolving a delisting threat that likely drove the 29% gain.

The headline confirms that SU Group Holdings received official written notification from Nasdaq that the company has regained compliance with minimum bid price requirements. This is a material event for a small-cap stock trading near low levels, as failure to meet the minimum bid price threshold typically triggers delisting proceedings. Regaining compliance eliminates that existential threat to shareholders and restores the stock's trading status, which explains the substantial single-day rally. The timing of the announcement late on 2026-08-20 aligns with the stock's inclusion in the day's top gainers. This is a straightforward compliance resolution event rather than an operational or financial announcement, but it is highly relevant to stock valuation because it removes delisting risk.

AIEV

Thunder Power Holdings, Inc.Consumer Cyclical

$0.20+$0.04

+28.2%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 28.21% gain in AIEV stock cannot be directly attributed to a named catalyst. The move likely reflects technical trading, a delayed announcement, or speculative activity common in low-priced stocks.

Thunder Power Holdings is a micro-cap stock trading at $0.20, and the absence of recent news headlines means we cannot point to a specific event like earnings, guidance, or a business development announcement. Penny stocks and ultra-low-priced equities often experience large percentage swings on modest volume from retail trading, short covering, or technical factors rather than fundamental news. It is possible that news was released but not yet picked up by Yahoo Finance RSS feeds, or that the move reflects accumulated buying pressure from earlier in the week. Without substantive information about Thunder Power's current business status, pending announcements, or technical setup, attributing this specific 28.21% move to any particular cause would be speculative.

AIFU

Fanhua Inc.Financial Services

$15.00+$2.90

+24.0%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours for AIFU, so the 24% gain cannot be attributed to a specific reported event. The move likely reflects technical trading, options expiry, delayed news dissemination, or unconfirmed rumors.

Fanhua Inc. (AIFU) posted a substantial one-day gain of 23.97% to rank eleventh among daily gainers, yet zero news headlines appeared in the Yahoo Finance RSS feed over the preceding 48 hours. This disconnect between price action and reported news is not uncommon in smaller-cap or lower-liquidity stocks. Possible explanations include short covering or short-squeeze dynamics if the stock has high short interest, technical chart breakouts triggering algorithmic or retail buying, options expiration effects, delayed publication of actual news (company announcement, earnings, analyst upgrade), or rumors circulating through social media or specialized forums before traditional news outlets report them. Without access to real-time order flow, insider trading data, or social sentiment analysis, it is impossible to isolate the specific trigger. The lack of news in the feed does not prove no news occurred, only that it was not captured by this particular data source within this time window.

CLPS

CLPS Inc

$1.06+$0.20

+23.9%

XOS

Xos, Inc.Industrials

$3.71+$0.67

+22.9%

NASDAQ · Mkt cap $41 M

Xos announced UL 2202 certification for its Xos Hub energy storage system on August 19, which validates safety standards and simplifies permitting and insurance processes for fleet customers, likely driving today's 22.88% gain.

The headline from August 19 indicates that Xos Hub achieved UL 2202 certification, a third-party safety validation that reduces regulatory friction for fleet operators. The certification makes the charging equipment easier to specify, permit, and insure in jurisdictions requiring independently listed equipment. For a company in the electric vehicle fleet charging space, third-party certifications that accelerate customer adoption and reduce operational barriers are material catalysts. This type of regulatory validation reduces perceived risk and shortens sales cycles. The timing of the announcement on the 19th and the stock's jump on the 20th aligns logically. No competing news or offsetting negative developments appear in the provided headlines. The gain ranks as the 13th largest on the exchange, suggesting broad market acknowledgment of the positive development.

GNLN

Greenlane Holdings IncConsumer Defensive

$3.52+$0.59

+20.1%

NASDAQ · Mkt cap $1.9 M

No news was reported in the last 48 hours for GNLN, so the 20% single-day jump likely stems from technical factors, short covering, sector momentum, or an undisclosed announcement not yet picked up by major financial news feeds.

Greenlane Holdings experienced a significant intraday rally with no corresponding headline news in the recent news sources provided. This disconnect between price action and available information suggests several possible drivers. The stock could be responding to positive sentiment in the cannabis or smoke accessories retail sector more broadly, a technical bounce from oversold conditions, short-squeeze activity if the stock carries notable short interest, or a material company announcement that has not yet been indexed by the Yahoo Finance RSS feed or major wire services. Without access to the company's official announcements, SEC filings, or real-time trading volume data showing unusual short-covering patterns, attribution remains speculative. The timing and magnitude of the move warrants checking the company's investor relations channels and after-hours filings for same-day disclosures.

USDEW

StablecoinX Inc. Warrants

$0.72+$0.12

+19.7%

OMH

Ohmyhome Limited - Ordinary SharesReal Estate

$0.10+$0.02

+19.6%

NASDAQ · Mkt cap $7.7 M

No news headlines appeared in the last 48 hours, so the 19.63% gain on OMH is unexplained by reported corporate events. The move likely reflects either technical trading, retail interest, or delayed news not yet indexed.

OMH moved from approximately $0.0835 to $0.10, a solid intraday gain that landed it in the top 20 gainers. However, no recent news headlines are available in the Yahoo Finance feed, which limits our ability to attribute the move to a specific catalyst. Penny stocks and micro-cap equities like OMH often exhibit sharp moves on thin volume driven by technical breakouts, short covering, retail trading momentum, or delayed dissemination of news not yet picked up by mainstream sources. The stock could have gapped on an after-hours announcement, an earnings report, a corporate action, or sentiment shift among retail traders. Without access to intraday news, SEC filings, or trading volume data, we cannot determine the root cause from the evidence at hand.

IDAI

T Stamp Inc.Technology

$3.18+$0.51

+19.1%

PTLE

PTL LTDConsumer Cyclical

$7.93+$1.41

+18.6%

NASDAQ · Mkt cap $50 M

No news headlines were found in the last 48 hours for PTLE, so the 18.6% gain today likely reflects either a delayed market reaction to an earlier announcement, technical trading, or a small-cap liquidity event.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for the 18.6% jump in PTLE stock. Small-cap stocks listed on NASDAQ, particularly those trading under $10, can experience outsized price moves on relatively light volume when sentiment shifts or when delayed information reaches the market. Possible explanations include a company announcement that has not yet been picked up by major news feeds, short covering if the stock has high short interest, technical breakout or gap fill trading, or market exuberance in a particular sector. Without access to company filings, real-time trading data, or verified news beyond the 48-hour window, we cannot definitively attribute this move to a fundamental catalyst.

SMTK

SmartKem, Inc.Technology

$0.10+$0.02

+18.6%

NASDAQ · Mkt cap $2.2 M

Smartkem announced a reverse stock split approved by its Board on August 19 to maintain Nasdaq listing compliance, likely triggering the 18.58% single-day gain as investors reacted to the delisting-prevention measure.

The headline confirms that Smartkem's Board approved a reverse stock split on August 19, 2026, explicitly to support continued Nasdaq listing eligibility. A reverse split consolidates shares, mechanically raising the per-share price while reducing share count, which can create a temporary perception of valuation improvement or reduced dilution risk among retail traders. The timing of the announcement on August 19 and the stock's move on August 20 aligns closely. However, reverse splits are generally neutral to negative long-term signals because they indicate the company has fallen below minimum price thresholds and face delisting risk. The sharp single-day gain suggests short-term technical or sentiment-driven buying rather than fundamental improvement, possibly driven by short covering, retail momentum, or traders reacting to the announced restructuring as a positive near-term signal despite the underlying distress it implies.

ZSTK

ZeroStack Corp.Financial Services

$5.75+$0.75

+17.7%

NASDAQ · Mkt cap $32 M

ZeroStack announced a $1 billion crypto contribution agreement with MemeCore on August 19, which likely drove the 17.66% single-day gain as investors reacted to the capital influx and expanded asset base for the AI-focused asset manager.

The company disclosed on August 19 that it entered a $1 billion crypto contribution deal with MemeCore that would add approximately 926 million tokens to its holdings. This represents a material inflow of capital and crypto assets for ZeroStack, an AI-focused asset management firm listed on Nasdaq. The timing aligns closely with the stock's jump to rank 20th among daily gainers. The news arrived on the heels of a separate corporate action—the completion of the company's continuance to Texas on August 18—which may have also supported investor sentiment. The scale of the $1 billion commitment and token acquisition appears sufficient to explain the magnitude of the move, as it materially expands the company's asset base and signals third-party confidence in its platform.

Missfresh LimitedCommunication Services

$17.64+$2.63

+17.5%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours, so the 17.49% gain cannot be directly attributed to a disclosed corporate announcement or market event. The move likely reflects technical trading, a delayed earnings report, or sector momentum.

The absence of recent headlines makes it impossible to pinpoint a specific catalyst for MF's sharp 17.49% intraday gain. Missfresh Limited is a Chinese grocery e-commerce platform, a sector that can experience volatile swings based on regulatory developments, quarterly results, or short-covering activity. Without confirmed news, the most probable explanations are either a delayed or overnight earnings announcement not yet captured in the Yahoo Finance feed, a technical rebound from oversold conditions, accumulation by short-squeeze traders, or sector-wide momentum in Chinese tech stocks. Occasionally NASDAQ tickers also move on unconfirmed rumors or analyst upgrades that take time to surface in mainstream feeds. The rank as 21 biggest gainer suggests this was a legitimate volume-driven move rather than a micro-cap spike.

NXTT

Next Technology Holding Inc.Technology

$7.97+$1.20

+17.2%

NASDAQ · Mkt cap $9.8 M

No news headlines were found in the last 48 hours, so the 17.19% jump cannot be attributed to a reported event; the cause remains unclear without additional information.

Despite a substantial single-day gain ranking NXTT as the 22nd biggest mover on NASDAQ, no relevant news headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect between price action and reported catalysts makes the underlying cause difficult to establish from available evidence. For a small-cap technology company like NXTT, a move of this magnitude without attributed news could reflect several possibilities: a delayed or embargoed press release not yet indexed by the RSS feed, technical trading (short covering, momentum algorithms, or chart breakout), social media or forum activity driving retail interest, or a corporate action (equity raise, insider transaction, or regulatory filing) that has not yet been widely reported. Without access to earnings dates, insider transactions, or competing news sources, any explanation would be speculative rather than grounded in fact.

EMAT

Evolution Metals & Technologies Corp.Basic Materials

$3.35+$0.49

+17.1%

NASDAQ · Mkt cap $2.0 B

No news headlines were published in the last 48 hours, so the 17.13% gain cannot be directly attributed to a specific announced event. The move is likely driven by technical trading, delayed market reaction to older news, or an undisclosed catalyst.

EMAT jumped 17.13% to rank 23 among daily gainers despite zero news coverage in Yahoo Finance's recent feeds. For a smaller-cap stock like EMAT trading at $3.35, such moves often reflect technical factors including short covering, options expiration effects, or momentum trading rather than fundamental news. Evolution Metals & Technologies as a materials or mining-adjacent name could also be responding to broader sector rotation, commodity price moves, or delayed market digestion of earlier announcements not captured in the 48-hour window. Without access to trade volume, short interest data, or older archived news, we cannot pinpoint whether this is genuine momentum from a real catalyst or speculative positioning.

GOAI

EVA LIVE INC.Technology

$2.00+$0.29

+16.9%

NASDAQ · Mkt cap $69 M

No news headlines were found in the last 48 hours for GOAI, so the 16.95% gain on August 20, 2026 cannot be attributed to a specific announced event. The move likely reflects technical trading, delayed news pickup, or market speculation.

The absence of recent Yahoo Finance headlines for EVA LIVE INC. makes it impossible to anchor the price move to a concrete catalyst. Micro-cap and small-cap stocks listed on NASDAQ, particularly those trading near $2.00, are often subject to retail trading activity, short covering, or technical breakouts that can drive outsized single-day gains without accompanying press coverage. The stock's rank as the 24th biggest gainer suggests material volume and interest, but without corroborating news, the underlying cause remains opaque. Possible categories include an unreported business update, options expiration effects, or algorithmic/retail-driven momentum trading. Without access to real-time filings, earnings calendars, or alternative news sources beyond the provided headlines, attribution remains speculative.

CBAT

CBAK Energy Technology IncIndustrials

$0.82+$0.12

+16.8%

NASDAQ · Mkt cap $62 M

CBAK Energy announced expansion of lithium-ion battery manufacturing capacity at its Nanjing facility on August 20, advancing production capabilities, which likely triggered the 16.82% intraday gain as a positive operational update for the battery maker.

The headline from August 20 at 13:20 UTC describes CBAK Energy expanding Model 32140 capacity at Nanjing Phase II and advancing digital manufacturing. This is a concrete operational announcement released the same day as the stock's jump, making it the most probable direct catalyst. The news signals production scaling and manufacturing modernization, which investors in battery makers typically view favorably as indicators of revenue growth potential and competitive positioning. The second headline about a Clean Energy Metals virtual investor conference from August 19 appears unrelated to CBAK Energy directly, though it may have contributed to broader sector sentiment. The stock's micro-cap status (trading under $1) and positioning in the Chinese EV battery supply chain make it sensitive to operational milestones and capacity announcements that can drive percentage swings.

SNSC

SunScout Holding LimitedTechnology

$1.47+$0.22

+16.7%

ARBB

ARB IOT Group Limited - Ordinary SharesTechnology

$5.02+$0.67

+16.6%

NASDAQ · Mkt cap $7.1 M

No news headlines were found in the last 48 hours, so the 16.58% gain on August 20 cannot be directly attributed to a reported catalyst. The jump likely stems from technical trading, delayed news dissemination, or market speculation.

ARB IOT Group Limited showed a strong single-day gain of 16.58%, ranking it as the 27th biggest gainer on the date, yet no corresponding news headlines appeared in the 48-hour window provided. This disconnect suggests several possibilities. First, the move could be purely technical—momentum trading, short covering, or algorithmic accumulation in a lower-volume stock. Second, material news may have circulated outside Yahoo Finance's RSS feed or on alternative channels before wider pickup. Third, the catalyst might be sector-wide momentum in IoT or semiconductor-adjacent stocks, or a delayed market reaction to older news. Without specific earnings, product announcements, partnerships, regulatory actions, or guidance changes visible in the headline data, attributing the move to a particular corporate event is not supported by the evidence provided.

BEAGR

Bold Eagle Acquisition Corp. Right

$0.24+$0.03

+16.3%

FRTT

Fort Technology Inc.Consumer Cyclical

$1.12+$0.16

+16.1%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours, so the 16% gain cannot be attributed to a disclosed catalyst. The move likely reflects technical trading, market sentiment shifts, or undisclosed developments.

Fort Technology Inc. jumped 16.15% to rank among the day's top 29 gainers, yet no earnings, product announcements, regulatory actions, or other material news appeared in the available headline feed over the preceding 48 hours. This disconnect between price action and public information suggests the move was driven by factors outside the typical news-based narrative: possible technical or algorithmic momentum, short-covering, retail trading activity, sector rotation, or delayed market reaction to a development not yet reflected in this news source. Without access to level-two market data, SEC filings released same-day, or social-media-driven sentiment, the specific trigger remains unknown.

SGLY

Singularity Future Technology Ltd.Industrials

$3.43+$0.45

+15.7%

NASDAQ · Mkt cap $2.7 M

Singularity announced a non-binding framework agreement for a 900-acre AI data center campus in South Carolina with up to 99MW expansion potential, a strategically significant AI infrastructure play that likely drove the 15.68% gain.

The most prominent catalyst is the August 20 announcement of a strategic development framework agreement with Florence Development LLC for a potential 900-acre AI data center campus in Florence, South Carolina, with approximately 25MW of existing or near-term grid capacity identified and a potential expansion pathway targeting up to 99MW. This represents a material pivot for a company previously described as a logistics integrated solution provider, positioning it in the high-growth AI data center infrastructure space. The timing coincides with surging investor appetite for AI infrastructure plays. The stock also saw two registered direct offerings totaling approximately $6.8 million priced within the same 48-hour window, which typically causes dilution but appears to have been overshadowed by the larger strategic infrastructure news. The framework agreement is non-binding, so execution risk remains, but the announcement alone appears sufficient to have catalyzed the jump.

FLUX

Flux Power Holdings, Inc.Industrials

$0.83+$0.11

+15.6%

NASDAQ · Mkt cap $16 M

Flux Power released its 2026 fiscal fourth quarter and full year financial results on August 20, triggering a 15.61% gain, likely reflecting positive earnings or guidance that reversed prior weakness in the micro-cap energy storage stock.

The news headline confirms that Flux Power announced fiscal year 2026 results on the exact date of the price surge. The headline text is truncated and does not provide specific financial metrics, so we cannot verify whether earnings beat estimates, revenue grew, margins improved, or guidance was raised. However, the timing alignment between the earnings release and the 15.61% jump is direct and unambiguous. For a micro-cap lithium-ion energy storage and fleet intelligence company trading at $0.83, results announcements are typically high-impact catalysts. The magnitude of the gain suggests the market viewed the results favorably, though without seeing the full earnings release we cannot isolate which metric (profitability, revenue growth, new contracts, technology validation) drove the move. Small-cap stocks in the energy storage sector are also sensitive to sector sentiment and competitive positioning.

MARA

Marathon Patent Group IncFinancial Services

$11.15+$1.50

+15.5%

NASDAQ · Mkt cap $4.5 B

Marathon Patent Group surged 15.48% on August 20th likely driven by the broader cryptocurrency rally, as Bitcoin climbed above $71,000 and other crypto-linked stocks rallied sharply, despite the company having reported earnings misses and expensive valuations just one day prior.

The recent headlines reveal a mixed picture for Marathon itself. On August 19th, the company reported Q2 2026 earnings that missed expectations, showing lower sales and a shift from profit to loss, with analysts questioning its valuation. However, on August 20th—the day of the stock's 15.48% jump—multiple headlines highlight a sector-wide cryptocurrency and Bitcoin mining rally. Circle and Bitdeer both surged on crypto strength, with Bitcoin breaking above $71,000 and a major AI infrastructure deal benefiting the mining sector. While Marathon's fundamentals appear weak based on the earnings miss, the timing of the gain coincides precisely with the broader crypto bull move. This suggests investors are responding to improving sector sentiment and Bitcoin strength rather than company-specific positive news, as no such news appears in the 48-hour window provided.

TRON

Toron, Inc.Consumer Cyclical

$1.87+$0.25

+15.5%

NASDAQ · Mkt cap $733 M

No news headlines were found in the last 48 hours for TRON, so the 15.48% gain cannot be directly attributed to a specific announced catalyst. The move likely reflects technical trading, market sentiment, or an undetected news event.

The absence of recent headlines in the provided data makes it impossible to point to a concrete catalyst for TRON's strong single-day performance. A 15.48% jump ranks it among the day's top gainers, which typically requires meaningful news such as earnings surprises, product announcements, strategic partnerships, or sector-wide momentum. Without that evidence, the move may stem from technical factors such as short covering, options expiration effects, or algorithmic trading. Alternatively, news may exist but was not captured in this Yahoo Finance RSS snapshot, or the move could reflect delayed market reaction to information from outside the 48-hour window. For a small-cap stock like TRON trading near $1.87, retail or institutional accumulation on modest volume can also produce outsized percentage gains.

RITR

Reitar Logtech Holdings Limited Ordinary sharesIndustrials

$0.09+$0.01

+15.5%

NASDAQ · Mkt cap $4.8 M

No news headlines were reported in the last 48 hours, so the 15.48% gain likely reflects either a technical bounce from oversold levels, a delayed market reaction to an earlier announcement, or speculative interest in a micro-cap stock.

The absence of any recent news headlines makes it impossible to identify a specific catalyst for RITR's +15.48% jump. At a price of $0.09, this is a micro-cap security where price moves can be volatile and driven by factors other than fundamental news, such as short covering, thin trading volume amplifying small buy orders, or retail investor interest. The stock's low price point and ranking as the 34th biggest gainer suggests this may be a speculative or technically driven move rather than one tied to corporate developments. Without access to intraday volume data, social media chatter, or prior-day context, attributing the move to any specific cause would be pure speculation.

HCACR

Hall Chadwick Acquisition Corp Rights

$0.29+$0.04

+15.2%

ACTU

Actuate Therapeutics, Inc.Healthcare

$1.22+$0.16

+15.1%

NASDAQ · Mkt cap $24 M

No news headlines were found in the last 48 hours, so the 15% gain on August 20th likely reflects a technical bounce, delayed market reaction to an older announcement, or sector-wide momentum rather than a fresh catalyst.

The absence of recent news makes it difficult to pinpoint a specific cause. Actuate Therapeutics is a small-cap biotech stock, and such stocks are prone to sharp intraday swings on low volume, short covering, or technical chart rebounds after prior declines. The move could also reflect a delayed market response to news released outside the 48-hour window, internal developments not yet covered by major news outlets, or momentum tied to broader biotech sector rallies. Without concrete recent headlines or knowledge of Actuate's current clinical pipeline status, short interest levels, or recent insider activity, attributing the gain to a specific fundamental catalyst is speculative.

ARCI

Appliance Recycling Centers of America IncFinancial Services

$0.60+$0.08

+15.1%

BGIN

Bgin Blockchain LimitedTechnology

$2.15+$0.28

+14.7%

NASDAQ · Mkt cap $225 M

No news headlines were found in the last 48 hours, so the 14.74% gain in BGIN on August 20, 2026 cannot be attributed to a confirmed catalyst from available sources.

The absence of recent news makes direct attribution impossible. Blockchain and cryptocurrency-related stocks are historically volatile and responsive to several categories of catalysts that may not always surface immediately in major RSS feeds: technical rebounds after oversold conditions, sector-wide sentiment shifts tied to crypto market moves, social media discussion or retail interest, short covering, or delayed disclosure of company developments. Without access to real-time trading data, SEC filings, or social sentiment metrics, the specific trigger for this 14.74% move remains unclear. The stock's placement as the 38th biggest gainer suggests noteworthy intraday volume and momentum, but those alone do not identify causation.

CELZ

Creative Medical Technology Holdings, Inc.Healthcare

$1.30+$0.17

+14.5%

NASDAQ · Mkt cap $7.1 M

Creative Medical Technology completed enrollment and treatment in its FDA-cleared ADAPT trial for Olastrocel in chronic lower back pain, with positive safety signals supporting advancement toward Phase 3, likely driving the 14.54% gain.

The company announced on 2026-08-20 that it has successfully enrolled and treated all patients across both the original and FDA-cleared expansion cohorts of its ADAPT trial for CELZ-201/Olastrocel. The headline emphasizes positive safety and early efficacy signals that support late-stage development planning. For a clinical-stage biotech company, completion of a major trial enrollment milestone with positive interim data typically triggers investor optimism, particularly when the company has regulatory clarity via FDA clearance and a clear pathway toward Phase 3 and potential RMAT (Regenerative Medicine Advanced Therapy) evaluation. The stock's ranking as the 39th biggest gainer on the day suggests market-wide recognition of the news as material and positive.

BTBT

Bit Digital, Inc.Financial Services

$1.60+$0.20

+14.3%

NASDAQ · Mkt cap $505 M

No headlines were available in the last 48 hours to explain the 14.34% gain in BTBT, making the cause unclear without additional information about market activity or company announcements released today.

Bit Digital is a Bitcoin mining and cryptocurrency infrastructure company, so its stock is typically correlated with Bitcoin price movements and the broader digital asset sentiment. The 14.34% jump with zero news headlines in the lookback period suggests the move may be driven by crypto market dynamics rather than company-specific news. Possible explanations include a significant Bitcoin price rally on August 20th, positive shifts in market sentiment toward mining equities, short-covering activity, or a delayed market reaction to an announcement made outside the RSS feed window. Without concrete information about Bitcoin's price action or any official company disclosures on the snapshot date itself, the exact catalyst remains speculative.

SNPX

Synaptogenix, Inc.

$3.68+$0.46

+14.3%

IAUX.WT

i-80 Gold Corp. WT

$1.05+$0.13

+14.1%

AIFC

AI Financial Corporation

$0.59+$0.07

+13.7%

SKYH.WT

Sky Harbour Group Corporation

$0.25+$0.03

+13.7%

INTS

Intensity Therapeutics, Inc. - Common StockHealthcare

$4.89+$0.58

+13.4%

NASDAQ · Mkt cap $11 M

No headlines were found in the last 48 hours, so the 13.37% gain cannot be attributed to a specific announced catalyst. The move likely reflects either a delayed market reaction to earlier news, technical trading activity, or sector-wide momentum in biotech.

Intensity Therapeutics is a clinical-stage biopharmaceutical company, and without recent news headlines to reference, the cause of today's 13.37% jump cannot be definitively established from the evidence provided. For companies in this sector, significant single-day gains typically correlate with clinical trial results, regulatory decisions from the FDA, partnership announcements, or shifts in investor sentiment toward biotech broadly. It is also possible that news was released outside the Yahoo Finance RSS feed captured here, or that the move reflects technical buying, short covering, or accumulation ahead of an expected announcement. Without confirmed reporting, any specific explanation would be speculation. The absence of headlines in a 48-hour window surrounding a top-50 daily gainer is notable and suggests either a gap in the data or a catalyst that has not yet been widely reported.

AUID

Ipsidy Inc.Technology

$0.48+$0.06

+13.2%

NASDAQ · Mkt cap $7.0 M

No news headlines were available in the last 48 hours for AUID, so the 13.20% gain cannot be attributed to a publicly reported catalyst. The move likely reflects technical trading, delayed news dissemination, or speculative interest in this micro-cap security.

The absence of any recent news headlines makes it impossible to identify a specific fundamental driver for the 13.20% jump in AUID on August 20, 2026. Ipsidy is a micro-cap identity verification and mobile security company trading at $0.48, a price range where stocks are often subject to technical bounces, short covering, options expiration effects, or retail speculation. Given the lack of reported earnings, partnership announcements, regulatory updates, or guidance changes in the available news feed, the catalyst is most likely either a technical rebound after recent weakness, delayed dissemination of news not yet picked up by major financial outlets, or algorithmic/retail trading activity common in this price and market-cap segment. Without headline evidence, any causal claim is speculative.

EUDA

Euda Health Holdings LimitedReal Estate

$14.20+$1.83

+12.9%

NASDAQ · Mkt cap $42 M

No news headlines were found in the last 48 hours, so the 12.89% gain likely reflects either delayed market reaction to an earlier announcement, technical factors, or an undisclosed catalyst not yet indexed by news feeds.

The absence of recent news headlines makes it difficult to pinpoint a specific catalyst for EUDA's strong 12.89% single-day gain. For a healthcare-focused company like Euda Health Holdings, typical drivers of such moves would include clinical trial results, regulatory approvals, partnership announcements, or earnings surprises. However, none of these appear in the available news feed. The stock's ranking as the 47th biggest gainer suggests material institutional interest, which typically accompanies substantive news. Possible explanations include a delayed market reaction to news released before the 48-hour window, a technical bounce after earlier weakness, short-covering activity, or an announcement made through channels not yet indexed by the RSS feed reviewed here. Without confirmed information, the specific cause remains speculative.

CYPH

Cypherpunk Technologies Inc.Financial Services

$1.18+$0.14

+12.7%

NASDAQ · Mkt cap $115 M

Cypherpunk Technologies surged 12.73% following the announcement of a $33.33 million equity partnership with Winklevoss Capital to launch what the company describes as the world's largest Zcash mining fleet, adding roughly 18% to Zcash network hashrate.

The headline establishes a concrete, positive corporate development: a significant capital infusion ($33.33 million in equity) from a well-known crypto investor alongside the operational launch of a major mining initiative. The deal appears to advance the company's stated treasury-building strategy by capturing a material share of Zcash network mining rewards. The Winklevoss backing likely added credibility and legitimacy in crypto investor circles. For a small-cap stock trading at $1.18, an equity raise of this magnitude combined with a tangible operational expansion represents material news that would logically trigger a positive repricing. The timing of the 12.73% jump aligns directly with the announcement window, suggesting investors responded to the specific deal terms and strategic implications rather than to an unrelated market event.

CAST

FreeCast, Inc. Class ACommunication Services

$1.86+$0.20

+12.6%

NASDAQ · Mkt cap $100 M

FreeCast announced a 28-channel Brazilian television distribution agreement on August 20, expanding its international streaming strategy, which likely drove the 12.59% gain as the market reacted positively to geographic diversification and growth prospects.

FreeCast disclosed an agreement with RBTI to bring 28 Brazilian television channels to its platform, framed as part of the company's preparation for an international rollout of its streaming Platform-as-a-Service (PaaS) model. For a micro-cap stock like CAST trading near $1.86, announcements of significant content deals or geographic expansion can trigger substantial single-day moves, especially if investors view it as validation of the company's ability to scale internationally or execute on stated growth strategies. The timing of the announcement on the same day as the stock's ranking as the 49th biggest gainer suggests the market responded directly to the news. Without access to trading volume, short interest data, or prior guidance on Brazilian expansion, we cannot rule out that this also triggered technical buying or covered shorts, but the headline provides a clear narrative catalyst.

MRVI

Maravai LifeSciences Holdings IncHealthcare

$8.29+$0.92

+12.6%

NASDAQ · Mkt cap $2.7 B

MRVI gained 12.55% on August 20, but the single available headline reports a sector-wide healthcare decline on the same day, leaving the specific catalyst for this stock's outperformance unexplained by the provided news.

The headline provided is a sector update stating that healthcare stocks fell late Thursday afternoon, which contradicts rather than explains MRVI's strong 12.55% gain. The timing and specificity of the sector decline do not account for why this particular stock moved sharply higher. Without additional company-specific news regarding earnings, product approvals, partnerships, or guidance, the root cause remains unclear. MRVI is a life sciences company focused on enabling technologies for drug development and manufacturing, so typical catalysts would include contract wins, capacity announcements, or M&A activity. However, none of these appear in the available headlines. The disconnect between sector headwinds and individual stock strength suggests either company-specific good news not captured in the provided feeds, a technical or sentiment-driven move, or delayed dissemination of material information.

Biggest Losers

Thu, Aug 20, 2026 50

ZVZZT

$25.02−$154.18

-86.0%

AACI

Armada Acquisition Corp. IFinancial Services

$2.47−$7.54

-75.3%

NASDAQ · Mkt cap $341 M

No news headlines were found in the last 48 hours to explain the 75% collapse in AACI stock price; the drop likely stems from a corporate event such as a SPAC merger termination, deal breakdown, or shareholder vote outcome that was not captured by the RSS feed.

Armada Acquisition Corp. I is a blank-check company (SPAC), and a 75% single-day loss is consistent with a catastrophic corporate event rather than normal market volatility. The absence of any news in the Yahoo Finance RSS feed over the past 48 hours does not rule out the occurrence of a material event; the news may have been released through direct company filings, investor relations channels, or sources not indexed by that particular feed. For SPACs, typical triggers for such magnitude declines include announcement of a failed merger, termination of a proposed business combination, shareholder rejection of a deal, material covenant breach, or regulatory blocking. Without access to SEC filings, press releases, or broader news sources, the exact cause cannot be determined from the data provided. The timing and severity strongly suggest an announced negative corporate development rather than technical selling or delayed rumor.

BRUNW

Boost Run Inc. Warrant

$7.79−$4.15

-54.2%

LOOP

Loop Industries IncBasic Materials

$0.65−$0.67

-49.7%

NASDAQ · Mkt cap $30 M

No news headlines were found in the last 48 hours, so the 49.69% drop cannot be attributed to a specific announced event. The decline likely reflects either a delayed market reaction to older news, technical selling pressure, or undisclosed company developments.

Loop Industries is a recycled plastics technology company, and a nearly 50% single-day drop without concurrent headlines is unusual. This suggests either that relevant news broke through channels not captured in the Yahoo Finance RSS feed provided, or that the market is reacting to information already in circulation but not freshly reported. For microcap stocks like LOOP trading near penny stock levels, causes of sharp declines typically include disappointing earnings or guidance released before the snapshot date, shareholder dilution announcements, loss of major contracts or partnerships, regulatory setbacks, or elevated short interest triggering forced covering in reverse. Without access to company announcements or press releases directly, it is impossible to pinpoint which category applies here.

SVVC

Firsthand Technology Value Fund IncFinancial Services

$0.00−$0.00

-46.5%

NASDAQ · Mkt cap $49 K

No news headlines were available in the last 48 hours to explain the 46.48% drop in SVVC, making the immediate catalyst unclear. The decline may reflect technical selling, a delayed announcement, or a market event specific to this closed-end fund.

SVVC is Firsthand Technology Value Fund Inc, a closed-end fund that invests in early-stage and venture-backed technology companies. The absence of any news in the 48-hour window preceding a 46% single-day loss is notable and suggests the catalyst was either not yet disclosed, occurred before the news cutoff, or was non-news-driven. Closed-end funds of this type are typically sensitive to market sentiment shifts in venture capital and technology sectors, changes in net asset value relative to market price, or redemption pressures. Without access to SEC filings, fund announcements, or broader market context for that date, we cannot distinguish between a fund-specific issue (portfolio impairment, dividend cut, share repurchase suspension) and a broader venture-tech drawdown.

GWH

ESS Tech, Inc.Industrials

$0.40−$0.29

-42.0%

NYSE · Mkt cap $23 M

ESS Tech announced a $3.2 million dilutive capital raise on the same day it reported Q2 revenue plunge tied to a platform pivot, triggering a 42% single-day sell-off as investors reacted to both financial weakness and shareholder dilution.

The stock fell 42% on August 20 following two concurrent negative catalysts. First, the company's Q2 2026 earnings call transcript revealed a significant revenue decline as ESS pivots its business to a sodium-ion Bridge platform, signaling execution risk and near-term revenue headwinds. Second, on the same day, ESS announced a $3.2 million registered direct offering and concurrent private placement, a classic dilutive capital raise that typically pressures stock price when a company is already reporting operational weakness. Together, these developments suggest the company needs cash precisely when its core business is contracting, a combination that triggers sharp sell-offs in growth-stage industrial stocks. Investors are likely pricing in both the pivot risk and the dilution simultaneously.

PFSA

Profusa, Inc.Healthcare

$7.67−$5.45

-41.3%

NASDAQ · Mkt cap $3.4 M

Profusa reported a widening Q2 net loss and limited cash resources despite progress on the G3 Vision Labs acquisition, triggering a 41% single-day sell-off as investors react to deteriorating financial fundamentals and execution risk.

The earnings headlines reveal two conflicting narratives. On the positive side, Profusa advanced conditions toward closing the G3 Vision Labs acquisition and secured $10.7 million in debt-to-equity conversions, providing near-term liquidity. However, the core message is that Q2 2026 net losses widened compared to prior periods, and the company explicitly flagged limited cash resources. For a small-cap biotech or diagnostics company trading at $7.67, a widening loss combined with tight cash burn runway typically triggers sharp sell-offs because it signals either dilutive equity raises ahead, aggressive debt restructuring, or failed commercialization traction. The acquisition itself, while meant to be accretive, may be perceived as high-risk given the acquirer's weak cash position. The magnitude of the decline (41%) suggests the market was either surprised by loss acceleration or already skeptical and viewed the financial update as confirmation of distress.

CDTG

CDT Environmental Technology Investment Holdings Limited ordinary sharesIndustrials

$1.83−$1.23

-41.0%

NASDAQ · Mkt cap $9.9 M

No news headlines were found in the last 48 hours, so the 41% single-day drop likely reflects either a delayed market reaction to an untracked announcement, a technical or liquidity event, or sector-wide pressure on environmental technology stocks.

The absence of any recent news on Yahoo Finance makes direct attribution impossible. CDT Environmental Technology Investment Holdings is a Chinese-listed environmental tech company traded on NASDAQ, and stocks in this category can experience sharp moves from several sources: delayed disclosure of quarterly results or regulatory filings not yet picked up by major news feeds, sudden changes in Chinese regulatory sentiment toward environmental firms, loss of a major contract, or technical selling in a thinly traded security. Environmental technology stocks have also faced headwinds from shifts in green energy policy and financing conditions. Without access to company filings, regulatory announcements, or real-time trading data, we cannot distinguish between fundamental news, technical breakdown, or liquidity stress. The 41% one-day loss warrants investigation into whether an earnings miss, guidance cut, or material adverse event occurred but has not yet propagated to mainstream financial news.

LGCL

Lucas GC LimitedTechnology

$0.08−$0.05

-39.9%

NASDAQ · Mkt cap $10 M

LGCL fell 39.85% with no news headlines in the last 48 hours, suggesting the move was driven by technical selling, a delayed announcement, or liquidity-driven repricing of this penny stock.

No recent news headlines were found to explain this severe single-day decline. LGCL is a low-priced NASDAQ stock, and stocks in this category are often subject to elevated volatility, thin liquidity, and technical trading dynamics that can produce outsized moves independent of fundamental news. The absence of news does not rule out a material development—an announcement could have occurred outside the 48-hour window, or market participants may be reacting to information from alternate sources. Alternatively, this could reflect profit-taking after a prior run, forced liquidation, or short-covering reversal. Without access to intraday volume data, options activity, or insider filings from the relevant period, we cannot pinpoint the catalyst with confidence.

DMAQ

Deep Medicine Acquisition Corp.

$0.96−$0.58

-37.7%

ZTG

Zenta Group Company LimitedIndustrials

$1.09−$0.57

-35.0%

NASDAQ · Mkt cap $30 M

No news headlines were found in the last 48 hours, so the 35% intraday drop cannot be attributed to a specific reported event. The decline likely reflects either a material announcement not yet captured in syndicated feeds, a technical or liquidity event, or market reaction to delayed news.

The absence of any recent headlines in the Yahoo Finance RSS feed over the past two days is notable given the severity of the move, which ranks ZTG among the day's eleven biggest losers. This could indicate several scenarios: first, a material announcement may have occurred but not yet been indexed by the news aggregator; second, the move could stem from a private placement, insider trading disclosure, or regulatory filing that precedes formal press releases; third, for a micro-cap stock like ZTG trading at $1.09, sharp moves can occur on thin volume without accompanying news, driven by technical factors, short covering reversals, or sector-wide pressure. Without access to SEC filings, earnings releases, or company press releases issued today, it is impossible to pinpoint the specific catalyst with confidence.

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.03−$0.02

-33.1%

NASDAQ · Mkt cap $1.1 M

No news headlines were found in the last 48 hours, so the 33% drop cannot be directly attributed to a specific announced catalyst; the decline likely reflects either technical selling pressure, broader market weakness in micro-cap stocks, or undisclosed developments.

The absence of any recent news makes it impossible to pinpoint a definitive cause for WTER's sharp 33% single-day decline. Alkaline Water is a micro-cap stock trading at $0.03, a price range typically associated with heightened volatility and thin liquidity where individual trades can move the price significantly. Without disclosed catalysts, the move could reflect several generic categories: technical breakdown below a support level, margin calls or forced liquidations in retail holdings, delayed market reaction to earlier unreported news, negative sentiment in the broader beverage or alternative beverage sector, or simply low-volume panic selling in a thinly traded security. Micro-cap stocks in this price range are also prone to manipulation and rumor-driven moves that may not be immediately visible in mainstream headlines.

BSAAR

BEST SPAC I Acquisition Corp. Rights

$0.09−$0.04

-31.6%

DFSCW

DEFSEC Technologies Inc.Industrials

$0.03−$0.01

-28.4%

SURG

Surge Holdings, Inc.Communication Services

$0.18−$0.07

-27.3%

NASDAQ

No news headlines were available in the last 48 hours to explain Surge Holdings' sharp 27.25% decline, so the trigger remains unclear but could involve sector weakness, technical breakdown, or undisclosed company developments.

The absence of any recent news headlines for SURG makes it impossible to pinpoint a specific catalyst for today's steep drop. Surge Holdings trades at a very low price point ($0.18), which often characterizes speculative, thinly-traded stocks vulnerable to sentiment shifts, technical breaks, or liquidity events. This tier of equity typically responds to company-specific catalysts like shareholder dilution announcements, missed operational milestones, sector downturns in the oil and gas services industry (Surge's core business), or broader risk-off sentiment affecting small caps. Without substantive news or a known structural feature of the security itself, the 27.25% move must be classified as data-insufficient.

BNCWW

CEA Industries Inc. WarrantIndustrials

$0.01−$0.01

-25.5%

NASDAQ

No news headlines were found in the last 48 hours to explain the 25.5% drop in this warrant. The decline is likely driven by deterioration in the underlying CEA Industries stock or broader warrant decay, but the specific catalyst is unknown.

With no recent news available, the cause of BNCWW's sharp drop cannot be directly identified from reported events. However, warrants are leveraged instruments whose value depends critically on the underlying stock price and implied volatility. A 25.5% single-day loss in a warrant typically signals either a significant drop in the underlying equity, a sharp decline in implied volatility, or time decay accelerating if the warrant is near expiration or deep out-of-the-money. Warrants also trade with wide bid-ask spreads and lower liquidity than common shares, making them prone to larger percentage swings on modest volume. Without news, the most likely explanations are either an unreported earnings miss, negative operational development, or technical liquidation in the underlying CEA Industries stock that cascaded into this warrant.

UAC.WT

$0.60−$0.20

-25.0%

BTCT

Btc Digital Ltd.Technology

$1.49−$0.44

-24.9%

NASDAQ · Mkt cap $14 M

BTCT fell 24.86% with no news headlines in the last 48 hours, making the specific catalyst unclear; the drop may reflect broader crypto market weakness, technical selling, or undisclosed company developments.

No headlines appeared in the last 48 hours to explain the sharp 24.86% decline in BTCT. Given that this is a Bitcoin-related digital asset company, the move could reflect broad cryptocurrency market turbulence, which often drives correlated losses across the crypto equity space independent of company-specific news. Alternatively, the stock may have experienced technical selling after hitting resistance, liquidation activity, or a negative announcement that has not yet been indexed by the news feed provided. Without access to the company's social media, press releases outside the Yahoo Finance RSS feed, or real-time market commentary, the precise driver remains unidentified.

AAP

Advance Auto Parts IncConsumer Cyclical

$42.42−$13.77

-24.5%

NYSE · Mkt cap $2.7 B

Advance Auto Parts stock plunged 24.51% after reporting a surprise comparable sales decline in Q2 2026, missing revenue expectations and disappointing full-year guidance despite beating earnings per share estimates, signaling weakening consumer demand in the DIY auto parts market.

The headlines establish a clear mismatch between headline earnings and operational reality. AAP beat EPS estimates by 27% but missed revenue by 1.66%, the more material disappointment. Multiple sources emphasize that comparable sales declined unexpectedly, with a larger-than-expected drop in the DIY customer segment offsetting growth in the Pro channel. The company also issued weaker full-year 2026 guidance. This pattern—where cost management produces a near-term EPS beat while underlying demand deteriorates—is particularly punishing for retail stocks because it signals structural headwinds rather than transient issues. The market's 24% selloff reflects concern that margin expansion cannot compensate for shrinking consumer spending on auto maintenance and repairs, a discretionary category sensitive to economic slowdown.

QTEX

QTREX Quantum Ltd.Technology

$0.84−$0.27

-24.2%

NASDAQ · Mkt cap $50 M

QTREX announced a $10 million registered direct stock offering of 11+ million shares on August 20, which triggered a 16% premarket drop and likely continued selling through the day, accounting for the 24% total loss as dilution concerns outweighed positive technology news from the prior day.

The primary catalyst is the registered direct offering announced on August 20. The company disclosed it would issue more than 11 million ordinary shares to raise $10 million, supported by an existing institutional investor and a new global institutional investor. This type of equity issuance typically triggers immediate selling pressure due to shareholder dilution concerns and downward pressure on per-share metrics. The news broke premarket on August 20 with an initial 16% decline, and the stock continued falling through the session to reach a 24% total loss, consistent with sustained selling as the market absorbed the dilution impact. The prior day's positive announcement about graphene-like carbon conversion technology and the DF INSU300 material launch appears insufficient to offset the dilution narrative that dominated August 20 trading.

MTNB

Matinas BioPharma Holdings IncHealthcare

$0.19−$0.06

-24.0%

NYSE · Mkt cap $1.3 M

No news headlines were found in the last 48 hours to explain the 24% drop, so the cause remains unclear without additional information on company-specific or market events.

Matinas BioPharma is a small-cap biopharmaceutical company, and the absence of any reported news in the past two days makes it difficult to pinpoint a definitive catalyst for the sharp decline. Biotech stocks of this size are often sensitive to clinical trial results, FDA decisions, partnership announcements, or shifts in cash runway expectations, any of which could trigger a major single-day move. The 24% drop could reflect a delayed market reaction to news from earlier in the week, technical selling driven by a failed price level, sector-wide weakness in small-cap biotech, or a development that has not yet been widely reported through major financial news channels. Without access to company filings, clinical updates, or insider trading activity, the specific trigger remains speculative.

AIXC

Aixcrypto Holdings IncTechnology

$1.18−$0.37

-23.9%

SXTC

China SXT Pharmaceuticals IncHealthcare

$3.63−$1.14

-23.9%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours to explain the 23.90% drop in SXTC stock, making the specific catalyst unclear based on available information.

SXTC experienced a significant single-day decline of nearly 24% with no corresponding news coverage in the provided sources. For a small-cap biotech or pharmaceutical stock like China SXT Pharmaceuticals, this magnitude of move typically correlates with catalysts such as clinical trial setbacks, regulatory adverse actions, earnings disappointments, insider selling disclosure, short squeeze reversal, or broader sector rotation. The absence of news coverage could indicate either that the move was driven by technical factors, delayed market processing of earlier announcements, or internal corporate developments not yet picked up by mainstream financial media. Given the company's China-based operations and NASDAQ listing, geopolitical or regulatory changes affecting Chinese pharma stocks could also play a role. Without corroborating headlines or structural context about the security itself, determining the root cause requires additional investigation beyond the snapshot provided.

TNON

Tenon Medical, Inc.Healthcare

$7.01−$2.30

-23.7%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours for TNON, so the 23.74% single-day drop cannot be attributed to a public announcement or disclosed catalyst. The cause remains unclear without additional information.

The absence of recent headlines on Yahoo Finance during the 48-hour window preceding this steep decline is notable. For a microcap or small-cap medical device company like Tenon Medical, large single-day losses can stem from several sources: disappointing clinical trial results, regulatory setbacks, insider selling, negative analyst reports, broader sector weakness, or short-covering squeezes in reverse. Given that this is ranked the 24th biggest loser of the day, it underperformed the broader market significantly. Without access to SEC filings, investor call transcripts, or company press releases released outside the RSS feed window, it is impossible to determine whether the move was driven by company-specific news, sector dynamics, or technical factors. The timing and magnitude suggest an material event, but the nature of that event cannot be established from the available evidence.

VTIX

Virtuix Holdings Inc.Technology

$1.26−$0.39

-23.4%

NASDAQ · Mkt cap $55 M

Virtuix reported strong Q1 FY2027 earnings with 150% order growth since Meta launch and expanding margins, yet the stock fell 23%, suggesting either a sell-the-news reaction, unmet guidance expectations, or execution concerns despite headline positives.

The headline announces genuinely positive results: orders up 72% year-over-year, 150% growth since the Omni One Meta launch, gross profit up 29%, and margin expansion from 17% to 30%. These are objectively strong metrics that would normally support a stock rally. The 23% drop despite this positive news could reflect several dynamics. First, sell-the-news: if the market had already priced in the Meta partnership's impact and had high expectations, a good print may not surprise sufficiently. Second, the headline is truncated and missing forward guidance; investors may have learned of disappointing guidance, slowing demand expectations beyond the current quarter, or margin concerns not captured in the snippet. Third, Virtuix trades at a very low absolute price ($1.26), characteristic of microcap or speculative stocks prone to volatile profit-taking and retail sentiment swings independent of fundamentals. Without the full earnings transcript or guidance details, the disconnect between strong historical results and a major selloff remains partially unexplained.

HVII

Hennessy Capital Investment Corp. VII Ordinary Shares

$8.18−$2.38

-22.6%

DBGI

Digital Brands Group, Inc.Consumer Cyclical

$9.32−$2.52

-21.3%

NASDAQ · Mkt cap $6.8 M

No news headlines were found in the last 48 hours for DBGI, so the 21.25% drop cannot be directly tied to a disclosed event. The decline may reflect technical selling, sector weakness, or undisclosed company developments.

The absence of recent news makes it difficult to pinpoint a specific catalyst for the sharp 21.25% decline in DBGI. Digital Brands Group is a relatively small-cap apparel and fashion brand company that can be sensitive to inventory management concerns, wholesale partner changes, or shifts in direct-to-consumer performance. Without headline evidence, the move could reflect delayed market reaction to an earlier earnings miss or guidance cut, broad retail sector weakness, or technical selling pressure in a lower-liquidity stock. Alternatively, undisclosed corporate events, insider transactions, or private news circulating before official disclosure sometimes precedes sharp moves in smaller public companies. Without access to the full news flow or intraday catalysts, we cannot confidently rule out any of these categories.

MRNA

Moderna IncHealthcare

$133.34−$34.49

-20.7%

NASDAQ · Mkt cap $58 B

Moderna fell 20.73% on August 20 after surging 175-177% the previous day on positive melanoma vaccine trial results, as investors took profits and analysts flagged stretched valuation and early-stage trial risk.

The headlines establish a clear two-day pattern. On August 19, Moderna announced positive clinical trial results for a melanoma vaccine developed with Merck, triggering a historic 175-177% single-day rally that made MRNA the top S&P 500 gainer. On August 20, the stock reversed sharply as investors liquidated those positions to lock in gains. Multiple analysts contributed to the reversal by noting that valuations now appear stretched with substantial optimism already priced in, and that the cancer vaccine results, while encouraging, represent early-stage data that may not warrant such extreme enthusiasm. One analyst downgraded Merck stock despite the vaccine win, suggesting skepticism about the durability of the move. The technical analysis mentioned in headlines indicates increasingly stretched conditions after such explosive momentum. This represents classic post-spike profit-taking combined with rational reassessment of valuation risk.

LTCH

Latch, Inc.Technology

$0.15−$0.04

-20.5%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 20% single-day drop in LTCH likely stems from either a delayed market reaction to earlier negative developments, technical selling pressure, or an undetected negative catalyst not yet surfaced in available news feeds.

The absence of any Yahoo Finance headlines in the 48 hours preceding this sharp decline makes direct attribution impossible. Latch is a smart-lock and access-control technology company that has historically been volatile and faced investor skepticism around cash burn, profitability timelines, and competitive pressure. A 20% single-day move without concurrent news coverage could reflect several scenarios: a delayed negative announcement that hasn't yet been widely distributed, accumulating technical weakness triggering stop-loss cascades, insider activity or rumors circulating before formal disclosure, earnings disappointment from a prior day that is still reverberating, or sector-wide weakness in hardware or IoT companies. Without access to SEC filings, insider transactions, or real-time trading data from the snapshot date, identifying the specific catalyst is not possible from the information provided.

RDACR

Rising Dragon Acquisition Corp. Rights

$0.08−$0.02

-19.9%

NASDAQ

No news was reported in the last 48 hours, so the 19.9% drop in RDACR cannot be attributed to a specific disclosed event. The decline likely reflects typical illiquidity and volatility in SPAC rights, which trade on thin volume and can swing sharply on minimal catalysts or technical factors.

Rising Dragon Acquisition Corp. Rights are a SPAC-linked security with inherent structural characteristics that drive price behavior independently of corporate news. Rights offerings typically trade with wide spreads and low volume, making them susceptible to large percentage moves from small absolute dollar trades or shifts in sentiment toward the underlying SPAC. Without any headline catalyst in the past 48 hours, the decline is most plausibly explained by either technical selling pressure, a shift in redemption expectations ahead of a SPAC vote or merger deadline, or simply routine illiquidity-driven volatility. SPAC rights are often among the last to recover in market downturns and can experience outsized declines during periods of reduced retail participation or negative sentiment toward blank-check vehicles generally.

FTFT

Future FinTech Group IncTechnology

$0.69−$0.17

-19.7%

NASDAQ · Mkt cap $1.8 M

No news headlines were found in the last 48 hours, so the 19.72% drop likely reflects either delayed reaction to an earlier announcement, technical selling pressure, or a microstock volatility event typical of penny-range securities.

The absence of any recent headlines makes it difficult to pinpoint a specific catalyst for FTFT's sharp decline. Future FinTech Group is a microcap stock trading near $0.69, a price range historically associated with higher volatility and thinner liquidity. The company operates in fintech, a sector sensitive to regulatory sentiment, funding environment shifts, and competitive pressures. Without recent news, the sell-off could reflect several possibilities: (1) reaction to an earnings report or guidance cut issued more than 48 hours ago that is still being priced in, (2) broad sector rotation away from speculative fintech plays, (3) technical breakdown through a support level triggering algorithmic or stop-loss selling, or (4) a development announced via press release or filing that did not appear in the Yahoo Finance RSS feed within the specified window. Microstock volatility often runs ahead of news discovery.

CATO

Cato Corp-The

$3.04−$0.74

-19.6%

EXYN

Exyn Technologies, Inc.Technology

$1.59−$0.39

-19.5%

LMFA

LM Funding America IncFinancial Services

$1.34−$0.31

-18.8%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 18.79% decline in LMFA cannot be attributed to a specific announced event. The drop likely reflects either technical selling pressure, delayed market reaction to older news, or broader market sentiment toward the stock.

The absence of recent news headlines makes it difficult to pinpoint a definitive cause for LMFA's sharp 18.79% single-day decline. This is particularly notable given the stock's already low price of $1.34, which typically signals a micro-cap or distressed security. Possible drivers of such a move without concurrent news include technical breakdown (stop-loss cascades or loss of support levels), sector-wide rotation out of small-cap financials, market makers widening spreads due to low liquidity, or delayed reaction to older developments not captured in the 48-hour news window. LMFA operates in the specialty finance sector, which has experienced periodic volatility and regulatory scrutiny. Without corroborating headlines, attribution remains speculative.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.06−$0.01

-18.7%

NASDAQ · Mkt cap $5.5 M

No news headlines were found in the last 48 hours, so the 18.67% drop cannot be attributed to a specific announced event. The decline likely reflects broad biotech weakness, technical selling, or undisclosed developments in a micro-cap pharmaceutical stock.

Hepion Pharmaceuticals is a small-cap clinical-stage biopharmaceutical company with limited public information flow on typical trading days. The absence of news in the last 48 hours means this drop was not driven by an earnings miss, FDA decision, trial result announcement, or other major corporate event reported through mainstream financial channels. For micro-cap biotech stocks trading below ten cents, price moves of this magnitude can result from several sources: sector-wide selloffs in early-stage drug developers, technical break-throughs of support levels on light volume, delayed disclosure of trial failures or regulatory setbacks, analyst downgrades, or short-term speculative unwinding. Without headlines or visible catalysts, the true driver remains opaque and could include private information asymmetries typical of penny stocks.

PWCM

PowerCompute, Inc.Financial Services

$1.34−$0.30

-18.4%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours for PowerCompute, so the 18.39% decline likely stems from technical selling, a delayed announcement, or sector-wide weakness unrelated to company-specific catalysts.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to identify a specific catalyst for PWCM's sharp 18.39% decline on August 20. For a micro-cap stock trading at $1.34, typical causes of large single-day drops without visible headlines include technical breakdown below support levels, options expiration effects, short-squeeze reversals, insider selling, delayed or embargoed news that has not yet been indexed, or broader market or sector rotation away from technology or speculative equities. Without access to company filings, insider transactions, or real-time news feeds, any specific explanation would be conjecture. The stock's rank as the 36th biggest loser of the day suggests this was a material, market-wide event or technical reversal rather than a minor trade anomaly.

EDSA

Edesa Biotech IncHealthcare

$4.72−$1.03

-17.9%

NASDAQ · Mkt cap $55 M

Edesa Biotech announced a $25 million public stock offering priced on August 19-20, which triggered an immediate selloff as investors reacted to the dilution and capital raise announcement.

The company announced a proposed public offering on August 19 and priced it at $25 million on August 20. The stock declined approximately 13% in premarket trading on August 20 following the pricing announcement, and closed down 18.27% after-hours on August 19, with the current snapshot showing a 17.94% loss for the trading day. This pattern is consistent with typical market reactions to equity dilution events, particularly for clinical-stage biotech firms where equity raises are viewed as dilutive to existing shareholders. The announcement and rapid pricing suggest the company needed capital, which investors interpreted as a negative signal regarding the company's financial runway and equity valuation. Secondary offerings at clinical-stage companies often trigger prompt selloffs as the market reprices the security to account for increased share count and reduced cash burn per share.

RCON

Recon Technology LtdEnergy

$3.64−$0.71

-17.3%

NASDAQ · Mkt cap $1.7 M

No news headlines were found in the last 48 hours, so the 17.27% drop likely stems from a delayed announcement, technical selling, market-wide weakness, or a sector-specific headwind not yet reflected in available news sources.

The absence of any recent headlines covering RCON in the last 48 hours creates a gap between the significant price action and publicly available catalysts. A one-day drop of this magnitude for a micro-cap stock like Recon Technology (trading at $3.64) can occur for several reasons unrelated to breaking news: technical breakdown below support levels, sector rotation out of oil services or energy stocks, liquidations tied to fund redemptions or margin calls, short-covering reversals, or delayed disclosure of material corporate events such as financing announcements, management changes, or business updates that may be announced after market hours or on investor relations channels before reaching mainstream news aggregators. Without corroborating headlines, the specific trigger remains unclear.

FGL

Founder Group Limited Ordinary SharesIndustrials

$0.30−$0.06

-17.1%

NASDAQ · Mkt cap $475 K

Founder Group announced a $1.5 million solar EPCC subcontract for a Malaysia project on August 20, yet the stock fell 17.06%, suggesting the market either viewed the contract as insufficient, doubted execution, or reacted to unrelated negative sentiment about the company or sector.

The news released on August 20 describes a concrete win—a $1.5 million subcontract from Founder Energy subsidiary for solar engineering, procurement, and construction work on a 29.99MW facility in Malaysia under the Corporate Green Power Programme. On its surface, a secured revenue contract is typically positive. However, the magnitude of the move (17% down) on the same day as the announcement indicates either (a) the market had expected a larger or higher-margin contract, (b) investors lack confidence in the company's ability to execute or recognize revenue, (c) the $1.5 million contract is immaterial relative to the company's needs or liabilities, or (d) the market is responding to a different negative catalyst not captured in these two headlines. Without context on FGL's market cap, burn rate, competitive position, or prior guidance, the disconnect between a contract announcement and a sharp price decline remains unclear.

AMPGZ

Amplitech Group, Inc. Series B Right

$0.24−$0.05

-16.7%

NASDAQ

No news emerged in the past 48 hours to explain the 16.7% drop in this Series B rights offering. The decline likely reflects either broader market weakness, reduced demand for the underlying shares or rights, or a delayed market reaction to prior information.

AMPGZ is a Series B preferred share right, a derivative security whose value depends on the price action and sentiment around Amplitech Group's common stock and capital structure. With zero headlines in the recent 48-hour window, the drop cannot be attributed to company-specific news. For a rights offering of this type, typical catalysts include weakness in the parent company's stock, diminished investor appetite for dilutive offerings, shifts in broader market liquidity, or execution concerns around the conversion or exercise terms. Without headline evidence, we cannot pinpoint the specific trigger, but the magnitude of the move suggests either a material shift in Amplitech's equity valuation or a technical correction in a thinly traded security where price moves can be volatile relative to trading volume.

TGE.WT

The Generation Essentials Group

$0.15−$0.03

-16.7%

NYSE

No news headlines were available in the last 48 hours to explain TGE.WT's 16.67% drop, so the cause remains unclear from publicly reported information.

The absence of recent news headlines makes it impossible to identify a specific catalyst for today's decline. TGE.WT is a warrant (note the .WT suffix), which means its price is highly sensitive to moves in the underlying stock and changes in implied volatility. The 16.67% drop could stem from several categories of cause: a sharp decline in the underlying Generation Essentials Group stock itself due to missed earnings, negative sector trends, or operational issues; a broader market selloff affecting small-cap or specialty equities; deterioration in warrant-specific factors such as time decay or implied volatility compression; or a delayed market reaction to an announcement made more than 48 hours ago. Without access to headline data or the underlying stock's performance on the same day, distinguishing between these possibilities is not feasible.

OLOX

Olenox Industries Inc.Industrials

$2.15−$0.41

-16.3%

NASDAQ · Mkt cap $3.7 M

Olenox announced a letter of intent to acquire natural gas and power-generation assets in West Texas on August 19, but the stock fell 16.33% the next day, suggesting the market either views the deal as value-destructive, overpriced, or faces skepticism about execution or financing risk.

The only headline in the 48-hour window is a positive M&A announcement on August 19 describing an LOI to expand the company's integrated energy and data-infrastructure platform with natural gas resources and West Texas infrastructure capabilities. Normally such announcements drive short-term gains or neutral reactions. However, the stock dropped sharply the following day, indicating the market has interpreted this deal negatively. Possible explanations include concern about acquisition price relative to synergies, dilution from financing, execution risk in a volatile energy market, or that the LOI terms were perceived as unfavorable. It is also possible the headline failed to disclose key deal terms (purchase price, structure, funding sources) that would have been available in the full press release and spooked investors who reviewed details.

EVAC.WT

EQV Ventures Acquisition Corp II WT

$0.32−$0.06

-15.8%

BTOG

Bit Origin LtdFinancial Services

$0.74−$0.14

-15.6%

NASDAQ · Mkt cap $3.6 M

No news headlines were available in the last 48 hours for BTOG, so the 15.64% drop cannot be attributed to a specific reported event. The decline likely reflects technical selling, sector weakness, or unannounced developments.

The absence of any news in Yahoo Finance's RSS feed over the last two days makes it impossible to tie BTOG's sharp decline to a named catalyst. Bit Origin is a cryptocurrency mining and blockchain infrastructure company trading at a low stock price, which makes it sensitive to sector sentiment, bitcoin price movements, and liquidity events. A 15.64% single-day loss in this category could stem from several sources: weakness in crypto asset prices, broader technology sector rotation, margin calls or forced liquidation if the company uses leverage, negative commentary on social media or forums without formal news release, or simply low trading volume amplifying normal price swings. Without corroborating headlines, any specific cause remains speculative.

ISSC

Innovative Solutions & Support IncIndustrials

$20.93−$3.85

-15.5%

NASDAQ · Mkt cap $330 M

No news headlines were published in the last 48 hours to explain ISSC's sharp 15.54% decline, so the cause remains unknown without additional reporting or company disclosures.

ISSC dropped significantly on August 20, 2026, but Yahoo Finance returned no headlines from the prior 48 hours that would account for the move. For a NASDAQ-listed company in the defense and aerospace software space, typical catalysts include quarterly earnings misses, contract losses or delays, margin compression, guidance cuts, competitive setbacks, or regulatory headwinds. The absence of news does not rule out an announcement made after market close on the 19th, a private disclosure to analysts, sector-wide weakness in defense IT stocks, or technical/algorithmic selling. Without access to contemporaneous press releases or SEC filings from the company itself, attribution remains speculative.

FLYX.WT

flyExclusive, Inc.

$0.15−$0.03

-15.5%

BBBYW

Neighborhood Intelligence, Inc. Warrants

$0.44−$0.08

-15.4%

MSS

Maison Solutions Inc. - Class A Common StockConsumer Defensive

$1.58−$0.28

-15.0%

NASDAQ · Mkt cap $1.6 M

No headlines were reported in the last 48 hours for MSS, so the 15% decline cannot be directly attributed to disclosed news; the cause likely involves market sentiment, technical selling, or undisclosed company developments.

MSS experienced a significant single-day loss of 15.04% with no corresponding news headlines available in the 48-hour window. This absence of disclosure makes it difficult to pinpoint a specific catalyst. For a micro-cap stock trading near $1.58, typical drivers of sharp declines include profit-taking after prior gains, broker downgrades or rating changes not yet syndicated to major feeds, insider selling signals, a failed capital raise or financing announcement, deterioration in business metrics released through non-headline channels, or broad sector weakness affecting micro-cap equities. Without access to MSS's fundamental position, recent earnings history, or capital structure, any attribution remains speculative. The timing and magnitude suggest either a discrete negative event not yet widely reported or technical liquidation driven by stop-loss orders or margin pressure.

GYGY

Game Your Game, Inc.Technology

$1.62−$0.26

-14.7%

NASDAQ · Mkt cap $25 M

Game Your Game announced a shareholder letter and early-access AI product release on consecutive days, but neither headline reveals specific financial results, guidance changes, or catalysts strong enough to justify a 14.71% single-day drop. The sell-off likely stems from broader market condition…

The two headlines from the past 48 hours both appear promotional in tone: one touts the platform's global reach across 140+ countries and 300 million tracked shots, and the other announces limited early access to a new AI product with general availability targeted for end of September 2026. Neither headline explicitly states earnings results, revenue beats or misses, margin expansion, nor any negative guidance revision. The shareholder letter headline is the most recent (same day as the price drop) but only the title is provided; the full content could contain disappointing financial metrics, lower guidance, or other material negatives not reflected in the snippet. Alternatively, this drop may reflect technical selling pressure, sector rotation out of smaller-cap tech stocks, or accumulated skepticism about the company's path to profitability despite reported user growth metrics.

EYPT

EyePoint Pharmaceuticals IncHealthcare

$5.40−$0.92

-14.5%

NASDAQ · Mkt cap $459 M

No relevant news about EyePoint Pharmaceuticals was provided in the headlines; the 14.5% drop likely reflects sector-wide pressure, clinical trial setback, regulatory concern, or profit-taking in a small-cap pharma stock without specific catalyst evidence here.

The only headline provided discusses Graham Holdings and Biglari Holdings, two diversified holding companies, and is completely unrelated to EyePoint Pharmaceuticals, a specialty pharmaceutical company focused on ophthalmology. No news directly addressing EyePoint's operations, clinical trials, regulatory decisions, earnings, or pipeline was included in the search results. For a small-cap pharma stock like EyePoint, typical catalysts for a 14.5% single-day drop include negative clinical trial data, FDA rejection or delay on a key program, unexpected safety findings, guidance reduction, institutional selling, or industry-wide biotech weakness. Without concrete headline evidence, we cannot determine which factor caused this move.